XML 60 R45.htm IDEA: XBRL DOCUMENT v3.26.1
Supplemental Income Statement Information - Scheduleof Disaggregated Revenues (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Disaggregation of Revenue [Line Items]    
Total revenues $ 11,005 $ 10,364
Life Sciences Solutions    
Disaggregation of Revenue [Line Items]    
Total revenues 2,219 1,954
Analytical Instruments    
Disaggregation of Revenue [Line Items]    
Total revenues 1,667 1,677
Specialty Diagnostics    
Disaggregation of Revenue [Line Items]    
Total revenues 1,124 1,130
Specialty Diagnostics | Intersubsegment Eliminations    
Disaggregation of Revenue [Line Items]    
Total revenues (71) (72)
Laboratory Products and Biopharma Services    
Disaggregation of Revenue [Line Items]    
Total revenues 5,995 5,603
Laboratory Products and Biopharma Services | Intersubsegment Eliminations    
Disaggregation of Revenue [Line Items]    
Total revenues (228) (214)
Total Reportable Segments    
Disaggregation of Revenue [Line Items]    
Total revenues 11,529 10,846
Total Reportable Segments | Life Sciences Solutions    
Disaggregation of Revenue [Line Items]    
Total revenues 2,636 2,341
Total Reportable Segments | Life Sciences Solutions | Biosciences    
Disaggregation of Revenue [Line Items]    
Total revenues 981 993
Total Reportable Segments | Life Sciences Solutions | Genetic sciences    
Disaggregation of Revenue [Line Items]    
Total revenues 655 677
Total Reportable Segments | Life Sciences Solutions | BioProduction    
Disaggregation of Revenue [Line Items]    
Total revenues 893 671
Total Reportable Segments | Life Sciences Solutions | Other    
Disaggregation of Revenue [Line Items]    
Total revenues 107 0
Total Reportable Segments | Analytical Instruments    
Disaggregation of Revenue [Line Items]    
Total revenues 1,716 1,718
Total Reportable Segments | Analytical Instruments | Chromatography and mass spectrometry    
Disaggregation of Revenue [Line Items]    
Total revenues 798 773
Total Reportable Segments | Analytical Instruments | Chemical analysis    
Disaggregation of Revenue [Line Items]    
Total revenues 285 286
Total Reportable Segments | Analytical Instruments | Electron microscopy    
Disaggregation of Revenue [Line Items]    
Total revenues 633 659
Total Reportable Segments | Specialty Diagnostics    
Disaggregation of Revenue [Line Items]    
Total revenues 1,142 1,148
Total Reportable Segments | Specialty Diagnostics | Clinical diagnostics    
Disaggregation of Revenue [Line Items]    
Total revenues 271 263
Total Reportable Segments | Specialty Diagnostics | ImmunoDiagnostics    
Disaggregation of Revenue [Line Items]    
Total revenues 230 217
Total Reportable Segments | Specialty Diagnostics | Microbiology    
Disaggregation of Revenue [Line Items]    
Total revenues 160 152
Total Reportable Segments | Specialty Diagnostics | Transplant diagnostics    
Disaggregation of Revenue [Line Items]    
Total revenues 121 113
Total Reportable Segments | Specialty Diagnostics | Healthcare market channel    
Disaggregation of Revenue [Line Items]    
Total revenues 430 474
Total Reportable Segments | Laboratory Products and Biopharma Services    
Disaggregation of Revenue [Line Items]    
Total revenues 6,036 5,640
Total Reportable Segments | Laboratory Products and Biopharma Services | Laboratory products    
Disaggregation of Revenue [Line Items]    
Total revenues 569 582
Total Reportable Segments | Laboratory Products and Biopharma Services | Research and safety market channel    
Disaggregation of Revenue [Line Items]    
Total revenues 1,827 1,727
Total Reportable Segments | Laboratory Products and Biopharma Services | Pharma services    
Disaggregation of Revenue [Line Items]    
Total revenues 1,741 1,607
Total Reportable Segments | Laboratory Products and Biopharma Services | Clinical research    
Disaggregation of Revenue [Line Items]    
Total revenues 2,128 1,939
Elimination of intersegment revenues    
Disaggregation of Revenue [Line Items]    
Total revenues (524) (482)
North America    
Disaggregation of Revenue [Line Items]    
Total revenues 5,705 5,513
Europe    
Disaggregation of Revenue [Line Items]    
Total revenues 2,957 2,624
Asia-Pacific    
Disaggregation of Revenue [Line Items]    
Total revenues 1,970 1,891
Other regions    
Disaggregation of Revenue [Line Items]    
Total revenues 372 337
Consumables    
Disaggregation of Revenue [Line Items]    
Total revenues 4,722 4,354
Instruments    
Disaggregation of Revenue [Line Items]    
Total revenues 1,555 1,626
Services    
Disaggregation of Revenue [Line Items]    
Total revenues $ 4,728 $ 4,384